###begin article-title 0
The CAPN10 Gene Is Associated with Insulin Resistance Phenotypes in the Spanish Population
###end article-title 0
###begin p 1
Conceived and designed the experiments: MES AR MSR. Performed the experiments: MES RRL. Analyzed the data: MES FJM. Contributed reagents/materials/analysis tools: JLGS MTML CZ AG MSR. Wrote the paper: MES.
###end p 1
###begin p 2
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 419 425 419 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 723 729 723 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 867 873 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 1144 1150 1144 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 1347 1353 1347 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
Cardiovascular disease is the leading cause of morbidity and mortality in the industrialized world. Familial aggregation of cardiovascular risk factors is a frequent finding, but genetic factors affecting its presentation are still poorly understood. The calpain 10 gene (CAPN10) has been associated with type 2 diabetes (T2DM), a complex metabolic disorder with increased risk of cardiovascular disease. Moreover, the CAPN10 gene has been associated with the presence of metabolic syndrome (MS) in T2DM and in polycystic ovary syndrome (PCOS). In this work, we have analysed whether the polymorphisms UCSNP44, -43, -19 and -63 are related to several cardiovascular risk factors in the context of MS. Molecular analysis of CAPN10 gene was performed in 899 individuals randomly chosen from a cross-sectional population-based epidemiological survey. We have found that CAPN10 gene in our population is mainly associated with two indicators of the presence of insulin resistance: glucose levels two hours after a 75-g oral glucose tolerance test (OGTT) and HOMA values, although cholesterol levels and blood pressure values are also influenced by CAPN10 variants. In addition, the 1221/1121 haplogenotype is under-represented in individuals that fulfil the International Diabetes Federation (IDF) diagnostic criteria for MS. Our results suggest that CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 136 139 136 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Horikawa1">[1]</xref>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 473 479 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 545 548 545 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Cox1">[2]</xref>
###xml 683 695 683 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10 locus</italic>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 798 801 798 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Fullerton1">[3]</xref>
###xml 965 971 965 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 998 1004 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">locus.</italic>
###xml 1235 1238 1235 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Song1">[4]</xref>
###xml 1240 1243 1240 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Tsuchiya1">[5]</xref>
The CAPN10 gene is located at 2q37 and encodes a ubiquitously expressed member of the calpain cysteine protease family. Horikawa et al. [1] positionally cloned CAPN10 as type 2 diabetes mellitus (T2DM) gene in Mexican American and Finnish populations. In that study, the common G allele of UCSNP43 polymorphism and the haplotype combination 112/121 (that comprises UCSNP43, -19 and -63 polymorphisms) were associated with an increased risk of T2DM. Since then, the role of CAPN10 has been examined in different ethnic groups with uneven results [2]. Genetic heterogeneity between populations is thought to be responsible for the different polymorphisms and haplotype combinations at CAPN10 locus that have been found associated with an increased risk of T2DM. In fact, a report by Fullerton et al. [3] has shown an unusual degree of geographic structure at this locus, especially at UCSNP19 and UCSNP63 sites, suggesting positive natural selection acting either on CAPN10 gene or on closely linked locus. Despite these differences, two meta-analyses have confirmed the association of the UCSNP43 G allele with a higher risk of T2DM, whereas showed that the effect of the 112/121 haplogenotype was over-estimated in the initial studies [4], [5]
###end p 4
###begin p 5
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 106 109 106 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Horikawa1">[1]</xref>
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Elbein1">[6]</xref>
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-OrhoMelander1">[9]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Baier1">[10]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Tschritter1">[14]</xref>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 721 727 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Ehrmann1">[15]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Gonzalez1">[16]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Gonzalez2">[17]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Vollmert1">[18]</xref>
###xml 476 481 <span type="species:ncbi:9606">women</span>
Genetic studies have associated UCSNP43, UCSNP19 and the haplotype combination reported by Horikawa et al.[1] with insulin levels [6]-[9]. Some of these genetic associations are accompanied by physiological studies that support the CAPN10 role in proinsulin processing, insulin secretion and insulin action [10]-[14]. In this way, other insulin related disorders have been linked to CAPN10 gene such as polycystic ovary syndrome (PCOS). PCOS is a common endocrine disorder of women of reproductive age, characterized by chronic anovulation, infertility and hyperandrogenemia. This syndrome, in which insulin resistance is considered a key feature, has been independently associated with CAPN10 allelic variants by Erhman et al.[15] and our group [16], [17] and has been recently confirmed in a meta-analysis [18].
###end p 5
###begin p 6
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-1">[19]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Ferrannini1">[20]</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Reaven1">[21]</xref>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Hong1">[22]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Chen1">[23]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Garant1">[24]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Shima1">[25]</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Wu1">[26]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Carlsson1">[27]</xref>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Kang1">[28]</xref>
###xml 714 722 <span type="species:ncbi:9606">patients</span>
Metabolic syndrome (MS) is characterized by abdominal obesity, atherogenic dyslipidemia, raised blood pressure, insulin resistance/glucose intolerance, prothrombotic and proinflammatory state [19]. Currently insulin resistance is considered the underlying mechanism for these metabolic alterations [20], [21]. The CAPN10 gene has been associated with several components of MS such as hypertension in Chinese [22], [23] and African-American [24], elevated body mass index (BMI) in Japanese [25], cholesterol levels in Chinese [26] and hipertrigliceridemia in obese Swedish individuals [27]. Recently, the 111/121 haplotype combination has been associated with an increased risk of metabolic syndrome in Korean T2DM patients [28]. However, an analysis of this gene in individuals that fulfil the diagnostic criteria of MS in general population has not been performed.
###end p 6
###begin p 7
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 234 240 234 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 555 561 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
The aim of this study was to analyse the role of CAPN10 allelic variants in genetic susceptibility to MS and related metabolic traits in a Spanish population-based survey. Our main outcome is the identification of association between CAPN10 gene variants and two estimators of insulin resistance: the glucose levels after an oral glucose tolerance test (OGTT) and the HOMA index. In addition, we have observed association with blood pressure and cholesterol levels and with MS under the IDF definition. Altogether, our results contribute to the notion of CAPN10 as an insulin resistance gene.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 9
###begin p 10
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-MartinezLarrad1">[29]</xref>
###xml 63 66 <span type="species:ncbi:9606">men</span>
###xml 88 93 <span type="species:ncbi:9606">women</span>
This population based study includes 899 non related Caucasian men (n = 427, 47.5%) and women (n = 472, 52.5%) who were recruited by a simple random sampling approach from a cross-sectional population-based epidemiological survey in the province of Segovia in Central Spain (Castille), aimed at investigating the prevalence of anthropometric and physiological parameters related to obesity and other components of MS [29]. The age of this population ranged between 35 and 76 years (mean age 54.03+/-11.69 years). Subjects with previous diagnosis of type 1 diabetes were excluded from the study. All subjects gave their written consent to participate in the study. The study protocol was approved by the Ethics Committee of the Hospital Clinico San Carlos of Madrid.
###end p 10
###begin title 11
Phenotype measurements
###end title 11
###begin p 12
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Anthropometric measurements included body mass index (BMI, kg/m2) and waist circumference (WC, cm). Systolic (SBP) and diastolic blood pressures (DBP) were measured three times in the seated position after 10 minutes of rest to the nearest even digit by use of a random-zero sphygmomanometer.
###end p 12
###begin p 13
###xml 565 570 <span type="species:ncbi:9606">Human</span>
After an overnight fast period, 20 ml of blood were obtained from an antecubital vein without compression. Plasma glucose was determined in duplicate by a glucose-oxidase method adapted to an Autoanalyzer (Hitachi 704, Boehringer Mannheim, Germany). Total cholesterol, triglycerides (TG) and high-density lipoprotein cholesterol (HDL-c) were determined by enzymatic methods using commercial kits (Boehringer Mannheim, Germany). Low-density lipoprotein cholesterol (LDL-c) was calculated by the Friedewald formula. Serum insulin concentration was determined by RIA (Human Insulin Specific RIA kit, Linco Research Inc., St Louis MO, USA).
###end p 13
###begin p 14
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Genuth1">[30]</xref>
###xml 333 337 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Matthews1">[31]</xref>
###xml 339 343 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Grundy1">[32]</xref>
An oral glucose tolerance test (OGTT) using 75 g of glucose was performed according to the WHO recommendations and the results were interpreted in accordance with Genuth et al.[30]. Insulin resistance was estimated by the homeostasis model assessment (HOMA-IR) method according to the formula: Insulin (muU/ml)xGlucose (mmol/l)/22.5 [31], [32].
###end p 14
###begin p 15
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Grundy1">[32]</xref>
###xml 510 514 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Alberti1">[33]</xref>
###xml 172 175 <span type="species:ncbi:9606">men</span>
###xml 183 188 <span type="species:ncbi:9606">women</span>
###xml 276 279 <span type="species:ncbi:9606">men</span>
###xml 291 296 <span type="species:ncbi:9606">women</span>
###xml 586 589 <span type="species:ncbi:9606">men</span>
###xml 607 612 <span type="species:ncbi:9606">women</span>
The metabolic syndrome status was established according to ATPIII definition (SM_ATPIII) [32]: presence of at least three components between abdominal obesity (WC>/=102 cm men, 88 cm women), hipertrigliceridemia (>/=150 mg/dl), hypertension (>/=85/130 mmHg), HDL-c (<40 mg/dl men, <50 mg/dl women) and fasting glucose>/=100 mg/dl. We have also classified subjects according to the recently International Diabetes Federation (IDF) worldwide definition of the metabolic syndrome for Europid populations (SM_IDF) [33]. In this last definition, central adiposity (defined as WC>/=94 cm for men and >/=80 cm for women) is a prerequisite risk factor for the diagnosis of the syndrome; two of the following factors are also necessary: raised TG level (>150 mg/dl) or specific treatment for this abnormality; reduced HDL-c (<40 mg/dl males, <50 mg/dl females) or specific treatment; raised blood pressure (SBP>/=130 mmHg or DBP>/=85 mmHg) or treatment of previously diagnosed hypertension, raised fasting plasma glucose (FPG>/=100 mg/dl) or previously diagnosed T2DM.
###end p 15
###begin p 16
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002953-t001">Table 1</xref>
Table 1 summarize the basal characteristics of the study population, expressed as phenotypic means+/-standard deviations for the quantitative traits and crude prevalences for the dichotomic traits.
###end p 16
###begin title 17
Baseline characteristics of study subjects.
###end title 17
###begin title 18
DNA extraction
###end title 18
###begin p 19
DNA extraction from 300 mul of frozen peripheral blood was performed in a MagNapure LC Instrument (Roche Diagnostics), using MagNa Pure LC DNA Isolation kit (Roche Diagnostics) according to the manufacturer's instructions. Aliquots of DNA at 5 ng/ul were obtained to carry out PCR reactions.
###end p 19
###begin title 20
Genotyping
###end title 20
###begin p 21
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Horikawa1">[1]</xref>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Evans1">[34]</xref>
We have determined allele status at the single nucleotide polymorphisms previously associated with metabolic syndrome traits UCSNPs-44,-43,-19 and -63 according the nomenclature and definitions reported by Horikawa et al.[1] and Evans et al.[34].
###end p 21
###begin title 22
UCSNP44 and -43
###end title 22
###begin p 23
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Gonzalez1">[16]</xref>
###xml 272 295 263 286 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAG GGC GCT CAC GCT TGC</named-content>
###xml 395 399 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Ronaghi1">[35]</xref>
These two SNPs were amplified in a same amplicon of 204 bp using previously described primers 43F/43R [16]. The reverse primer was biotin labeled for genotypes determination in a PSQtrade mark 96 (Pyrosequencing AB, Uppsala, Sweden). The internal sequencing primer was 5' CAG GGC GCT CAC GCT TGC 3'. This instrument allows the simultaneous analysis of 96 samples using pyrosequencing techniques [35].
###end p 23
###begin title 24
UCSNP19
###end title 24
###begin p 25
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Gonzalez1">[16]</xref>
This polymorphism was amplified using previously described forward primer (19F) [16] and new designed reverse primer (19R2: 5'-GCA GGG TCT AAG CAG CAG CTA C-3'). Amplicon sizes were 152 bp for allele 1 (2 repeats of 32 bp sequence) and 184 bp for allele 2 (3 repeats of 32 bp sequence) and were differentiated in 2% agarose gel.
###end p 25
###begin title 26
UCSNP63
###end title 26
###begin p 27
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Gonzalez1">[16]</xref>
Allele status was determined using previously described procedure [16].
###end p 27
###begin title 28
Statistical Analysis
###end title 28
###begin p 29
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Sasieni1">[36]</xref>
###xml 255 260 <span type="species:ncbi:9606">Human</span>
To analyze differences in genotype distribution, chi-square association studies for MS and T2DM and test for deviation of Hardy-Weinberg equilibrium (HWE), we have used tests adapted from Sasieni [36] at the online resource available at the Institute for Human Genetics, Munich, Germany ().
###end p 29
###begin p 30
###xml 485 486 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 542 543 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
For genotype quantitative analysis, we have performed an analysis of variance using the GLM procedure included in SPSS software (Ver. 11.0.0., LEAD Technologies, Inc). Normality of the dependent variables was assessed by Kolmogorov-Smirnov test and, when necessary, we applied mathematical transformations (natural logarithm or square root) prior to the analysis. The adjusted percentage of the phenotypic variance explained by each genotype was estimated by subtracting the adjusted R2 value for a model that includes the genotype from the R2 for a model that excludes it. The Levenes test of equality of error variances was also performed for each analysis. In addition, all values from individuals under antihypertensive, antidiabetic or hypocholesterolemic medication were eliminated of the QTL analysis.
###end p 30
###begin p 31
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Tregouet1">[37]</xref>
Haplotype analysis was performed using the THESIAS software () based on the SEM algorithm [37]. This method allows to estimate haplotype frequencies and haplotype effects by comparison to a reference (the intercept) taken here as the most frequent one. Haplotypes effects are expressed as mean effects (increases/decreases of the phenotypic mean with respect to the intercept's one).
###end p 31
###begin p 32
All the studies were adjusted for sex, age, BMI, smoking (defined as present or past history of smoking of at least five cigarettes per day for a minimum of 5 years), alcohol consumption (defined as a daily intake of more than 10 g), and physical activity. Interaction effects of age, sex and BMI were explored.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
Genotypic association analysis
###end title 34
###begin p 35
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loci</italic>
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 245 252 245 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002953-t002">Table 2</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Gonzalez1">[16]</xref>
Allele 1 frequencies at the four polymorphic loci within CAPN10 gene (UCSNP44, -43, -19 and -63) in our population were 0.85 at UCSNP44 (allele T), 0.74 at UCSNP43 (allele G), 0.36 at UCSNP19 (2 repeats of 32 bp) and 0.95 at UCSNP63 (allele C) (Table 2). These allelic frequencies do not differ from previously determined by our group in healthy controls from Granada, Southern Spain (p>0.06) [16]. All genotypic frequencies fit those expected by the HWE (p>0.06), except for the UCSNP63 polymorphism, for which we detected a high degree of homozygosity (p = 0.002); genotypes of five out the eight individuals homozygous for the polymorphic allele at this locus were confirmed by direct sequencing.
###end p 35
###begin title 36
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
Genotype distribution at CAPN10 UCSNP44, -43, -19 and -63 sites and analysis of Hardy-Weinberg equilibrium (HWE).
###end title 36
###begin p 37
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 48 51 48 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Horikawa1">[1]</xref>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Evans1">[34]</xref>
Allele nomenclature according to Horikawa et al.[1] and Evans et al.[34]
###end p 37
###begin p 38
###xml 112 113 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 113 119 111 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 d.f.</sub>
###xml 248 255 246 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002953-t003">Table 3</xref>
###xml 827 833 825 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
The genotype distributions at UCSNP44 and UCSNP19 loci were shown to influence glucose levels after an OGTT (chi22 d.f., p = 0.008 and p = 0.011 respectively), explaining each of them around a 3% of the phenotypic variance observed for this trait (Table 3). Individuals homozygous for the less frequent alleles C at UCSNP44 and 2-repeats allele at UCSNP19 loci were associated with a significant lower glucose levels when compared with the remaining genotypes; conversely, homozygotes for the more frequent alleles (T at UCSNP44 and 3-repeats allele at UCSNP19), have higher OGTT values. Both UCSNP44 and UCSNP19 polymorphisms are also associated with the HOMA index, an indirect measure of insulin resistance; this trait is also influenced by the UCSNP43 locus. The effect size observed in terms of HOMA variance explained by CAPN10 polymorphisms is higher than the observed for the 2-hours glucose levels, being all of them over a 4.6%.
###end p 38
###begin title 39
Genotypic association analysis.
###end title 39
###begin p 40
Only the association studies which obtained a p value under 0.05 are shown. SE: standard error; Ns: Not significant. All values are adjusted by age, sex, alcohol consumption, smoking, physical activity and BMI.
###end p 40
###begin p 41
###xml 223 224 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The UCSNP19 polymorphism was also associated with two other MS related phenotypes: blood pressure (BP) and LDL-c levels, although the contribution to the phenotype is more modest that the observed for OGTT and HOMA (1.1>/=r2</=2.4). Heterozygotes for this variant have lower BP values despite increased LDL-cholesterol levels whereas the homozygous presence of allele 2 is associated with lower LDL-c levels.
###end p 41
###begin p 42
We have also observed that homozygotes for the UCSNP63 wild type allele have lower total and LDL cholesterol levels (p</=0.027) but given the departure of the HWE observed at this locus, these results must be interpreted with caution.
###end p 42
###begin p 43
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
We have not found any association with BMI, waist circumference, triglycerides or HDL-c values (data not shown). We have neither observed association with T2DM nor with MS_ATPIII, but the heterozygous presence of the UCSNP19 polymorphism was associated with a higher risk for MS_IDF (OR = 1.89 [1.04-3.44], p = 0.036). Interaction analyses of CAPN10 variants with age, sex and BMI were not significant, suggesting that the effects of these polymorphisms do not differ substantially between subjects for these reasons.
###end p 43
###begin title 44
Haplotypic association analysis
###end title 44
###begin p 45
###xml 191 198 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002953-t004">Table 4</xref>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
The haplotype reconstruction showed five possible haplotypes (1121, 1221, 2111, 1111 and 1112 for UCSNP44, UCSNP43, UCSNP19 and UCSNP63) according to previous reports from other populations (Table 4). Haplotypic frequencies are 0.37 for 1121, 0.25 for 1221, 0.15 for 2111, 0.16 for 1111 and 0.06 for 1112. For performing the association analysis, CAPN10 haplotypes were compared with a reference haplotype, taken here as the most frequent one (haplotype 1121). In this analysis, we only observed a significant contribution of the 2111 haplotype to the OGTT (p = 0.002), having the carriers of this haplotype 9.8% lower 2-hours glucose levels in accordance to the genotypic association analysis, since allele 2 at UCSNP44 locus only appears in this background.
###end p 45
###begin title 46
Haplotypic frequencies and association analysis with OGTT values in Spanish population
###end title 46
###begin p 47
F: population frequency.
###end p 47
###begin title 48
Haplogenotypic association analysis
###end title 48
###begin p 49
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002953-t005">Table 5</xref>
###xml 463 464 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 464 470 462 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7 d.f.</sub>
###xml 612 613 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 613 619 609 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7 d.f.</sub>
###xml 644 645 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 645 651 639 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7 d.f.</sub>
Finally, we have assigned haplotype pairs to all study subjects and performed haplogenotypic association analysis. In our population we identified fifteen haplogenotypes ranging in frequency from 0.93% to 17.11% (Table 5). In order to estimate the global haplogenotypic effect in the association analysis, only the haplotype pairs with a population frequency over 0.05 were computed. The only trait for which this global test was significant was LDL-c levels (chi27 d.f., p = 0.027), with two associated protective haplogenotypes (1221/1121 and 2111/1111), whereas a trend was observed for total cholesterol (chi27 d.f., p = 0.054) and SBP (chi27 d.f., p = 0.063). Given that LDL-c is the main fraction of total cholesterol, a high concordance is observed in the association analysis since 1221/1121 and 2111/1111 are also total cholesterol lowering haplogenotypes, although the effect size is lower.
###end p 49
###begin title 50
Haplogenotypic association analysis.
###end title 50
###begin p 51
Results are given as p-values. Numbers in brackets represents the percentages of increase or decrease of the phenotypic mean with respect to the remaining haplotypes. All values are adjusted by age, sex, alcohol consumption, smoking, physical activity and BMI.
###end p 51
###begin p 52
For SBP only the 2111/1221 haplogenotype individual analysis was significant (p = 0.024), showing a 3.8% decrease with respect to the remaining haplogenotypes. The 2111/1121 haplogenotype was associated with a reduction in both insulin and HOMA values (12.9%, p = 0.027 and 15.3%, p = 0.037 respectively) whereas the homozygous presence of the 2111 is associated with a significant decrease (18.4%) of the glucose levels after an OGTT (p = 0.016).
###end p 52
###begin p 53
Finally, the homozygous presence of the UCSNP19 polymorphism in the 1221/1121 haplogenotype is associated with a lower risk of suffering from MS_IDF (OR = 0.51 [0.26-0.99], p = 0.044). No association was observed with either MS_IDF or T2DM.
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 397 409 397 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10 locus</italic>
###xml 631 637 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 671 674 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Song1">[4]</xref>
###xml 676 679 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Tsuchiya1">[5]</xref>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-DiazVillasenor1">[12]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Norton1">[13]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Weedon1">[38]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Brown1">[39]</xref>
###xml 44 49 <span type="species:ncbi:9606">human</span>
Complex disorders represent the majority of human diseases, but their genetic bases are still unclear. CAPN10 gene has been associated with type 2 diabetes in some studies, but other analyses failed to reproduce this finding. It may be due to differences in effect size in different ethnic backgrounds, disease allele frequencies, marker allele frequencies and extent of linkage disequilibrium at CAPN10 locus between populations that also accounts for the diverse CAPN10 alleles associated with insulin resistance phenotypes in those studies. However, distinct meta-analyses and also functional studies have confirmed the role of CAPN10 in insulin resistance phenotypes [4], [5], [12], [13], [38], [39].
###end p 55
###begin p 56
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Tschritter1">[14]</xref>
###xml 861 865 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Evans1">[34]</xref>
###xml 867 871 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Weedon1">[38]</xref>
###xml 1107 1113 1107 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 1125 1128 1125 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Horikawa1">[1]</xref>
###xml 1191 1192 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1192 1193 1192 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1311 1315 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Weedon1">[38]</xref>
We have observed increased levels of both 2-hours glucose and HOMA values associated with the UCSNP44 TT genotype. Conversely, homozygous presence of the allele C (allele 2) is associated with higher glucose tolerance. This allele seems to be the most determining one in our population, since the unique haplotype in which the allele 2 exists was the only associated in the haplotypic analysis. Moreover, all but one of the haplogenotypes associated to the different phenotypes analysed comprise this allele. In all cases, the allele C confers protection from cardiovascular risk, not only regarding OGTT, HOMA or even insulin levels, but also regarding BP and plasma cholesterol. However, given the low frequency of this allele, we can not draw final conclusions. Previous studies have described an association of the allele C at UCSNP44 locus with T2DM [14], [34], [38]. This divergence could be related to specific population genetic background or to random chance in our results due to low population frequency. Functional studies suggest that UCSNP44 is located in an enhancer element and might affect CAPN10 expression [1]. Also this polymorphism is in perfect linkage disequilibrium (r2 = 1) with a missense mutation Thr504Ala (SNP-110) and two polymorphisms in the 5'-UTR region (UCSNP134 and UCSNP135) [38].
###end p 56
###begin p 57
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Gonzalez1">[16]</xref>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Vollmert1">[18]</xref>
###xml 532 537 <span type="species:ncbi:9606">women</span>
The other outstanding polymorphism in our population is UCSNP19, which is also associated with the OGTT and HOMA values, increased in the homozygotes for the 3-repeats allele (allele 2), and with LDL-c levels, that are in contrast decreased in these individuals. This antagonistic action is also observed in the heterozygous state, resulting in lower BP values despite increased LDL-c levels. The UCSNP19 polymorphism has been previously associated with other insulin resistance syndrome, PCOS, and with cholesterol levels in these women [16]-[18].
###end p 57
###begin p 58
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Horikawa1">[1]</xref>
We have not found evidence of association either of the UCSNP43 G allele or the 112/121 haplogenotype originally described by Horikawa et al [1] as T2DM susceptibility variants, with any of the metabolic related traits analysed in this work. By contrast, the UCSNP43 A allele (allele 2) which is in complete LD with UCSNP19 allele 2, seems to be related to higher HOMA values in our population, but only in the homozygous state. The unique haplotype in which the UCSNP43 allele 2 is present (haplotype 1221), when combined with the 1121 haplotype, is associated with a lower risk of MS_IDF suggesting that the effect of the UCSNP43 only exists in the homozygous state or that the association of the 1221/1121 with MS_IDF is due to the heterozygous presence of the UCSNP19 allele 2. However, the haplogenotypic analysis is the least powerful one due to reduced sample size in each analysed group, so we can not rule out the possibility of type 1 error, especially given that we have not applied correction for multiple testing.
###end p 58
###begin p 59
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002953-t006">Table 6</xref>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">locus</italic>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Kang1">[28]</xref>
###xml 600 606 600 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Xu1">[40]</xref>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 889 892 889 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-OrhoMelander1">[9]</xref>
###xml 914 920 914 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 920 923 920 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Lynn1">[8]</xref>
###xml 1349 1361 1349 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10 locus</italic>
###xml 1443 1446 1443 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Fullerton1">[3]</xref>
###xml 1448 1452 1448 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Clark1">[41]</xref>
###xml 1454 1458 1454 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-VanderMolen1">[42]</xref>
###xml 1555 1559 1555 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Neel1">[43]</xref>
We have observed increased total and LDL cholesterol values associated with heterozygosity at UCSNP63 locus, but given the high deviation from HWE observed in our population, we must interpret this result with caution. Interestingly, the T2DM and MS subpopulations are in HWE (p = 1.000 and p = 0.115, respectively) (Table 6). We have examined HWE at UCSNP63 locus in the report by Kang et al. [28]. We found that deviation from HWE (HWD) exists in this T2DM population, with an excess of allele 2 homozygotes (p = 0.0004) and an inbreeding coefficient F of 0.18. Conversely, in a recent analysis of CAPN10 performed on 312 healthy Korean subjects, HWD is not observed (p = 0.543) [40]. In Caucasians, a CAPN10 gene analysis in the Botnia region of Finland, shows that HWE is also altered in the control population (Finland) (p = 0.045) but is preserved in the T2DM population (p = 0.416) [9]. In a report by Lynn et al.[8], there is no evidence of HWD in a non diabetic British population (p = 0.170), but an independent analysis according to T2DM familial antecedents, shows that it is only true in those individuals with T2DM relatives, showing the individuals without T2DM familial antecedents again an excess of UCSNP63 allele 2 (p = 0.037). These data could reflect the existence of selective pressures and high geographic structure affecting CAPN10 locus identified by several reports in accordance with the thrifty genotype hypothesis [3], [41], [42]. This hypothesis posits that T2DM genes have been submitted to the effects of natural selection [43].
###end p 59
###begin title 60
Analysis of Hardy-Weinberg equilibrium (HWE) at UCSNP63 locus in different populations.
###end title 60
###begin p 61
FA: familial antecedents of T2DM.
###end p 61
###begin p 62
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loci</italic>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAPN10</italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19</italic>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Cox2">[44]</xref>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP19</italic>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Poretsky1">[45]</xref>
###xml 993 997 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002953-Jones1">[46]</xref>
###xml 777 781 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 783 787 <span type="species:ncbi:10090|species:ncbi:10095">ArKO</span>
In summary, our results support a role for CAPN10 in MS and related metabolic traits. However, the physiological mechanisms underlying the genetic associations described in this and other reports are not entirely clear. The pleiotropic effects of CAPN10 could be related with the key role of insulin in the harmonization of glucidic and lipidic metabolisms. The identification of other loci interacting CAPN10 could provide clues about the physiological pathways involved. In this way, genetic interaction between CAPN10 and CYP19 gene has been suggested to increases susceptibility to T2DM [44]. CYP19 aromatase encodes an enzyme involved in the steroid hormones synthesis from cholesterol, a biological process in which insulin is known to take part [45]. Aromatase knockout mice (ArKO) show increased intra-abdominal fat distribution and reduction of glucose oxidation, suggesting an important role for this metabolic route in the maintenance of lipid homeostasis in both males and females [46]. Members of the calpain family are involved in several biological processes through the proteolitic regulation of numerous transcription factors, but the physiological substrates for CAPN10 are still unknown. Further analysis considering gene-gene interactions will help resolve these questions.
###end p 62
###begin p 63
We are deeply grateful to Ana Salinas for technical support. We also thank Antonio Gonzalez for statistical counseling.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.
###end article-title 65
###begin article-title 66
Linkage of calpain 10 to type 2 diabetes: the biological rationale.
###end article-title 66
###begin article-title 67
Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus.
###end article-title 67
###begin article-title 68
Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies.
###end article-title 68
###begin article-title 69
Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses.
###end article-title 69
###begin article-title 70
Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians.
###end article-title 70
###begin article-title 71
Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort.
###end article-title 71
###begin article-title 72
Variation in the calpain-10 gene affects blood glucose levels in the British population.
###end article-title 72
###begin article-title 73
Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels.
###end article-title 73
###begin article-title 74
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.
###end article-title 74
###begin article-title 75
Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans.
###end article-title 75
###begin article-title 76
###xml 90 98 <span type="species:ncbi:9606">patients</span>
The activity of calpains in lymphocytes is glucose-dependent and is decreased in diabetic patients.
###end article-title 76
###begin article-title 77
###xml 42 47 <span type="species:ncbi:9606">Human</span>
Calpain-10 Gene and Protein Expression in Human Skeletal Muscle: Effect of Acute Lipid-Induced Insulin Resistance and Type 2 Diabetes.
###end article-title 77
###begin article-title 78
Assessing the shape of the glucose curve during an oral glucose tolerance test.
###end article-title 78
###begin article-title 79
Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.
###end article-title 79
###begin article-title 80
Comment: CAPN10 alleles are associated with polycystic ovary syndrome.
###end article-title 80
###begin article-title 81
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
###end article-title 81
###begin article-title 82
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.
###end article-title 82
###begin article-title 83
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
###end article-title 83
###begin article-title 84
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
###end article-title 84
###begin article-title 85
###xml 52 57 <span type="species:ncbi:9606">human</span>
Banting lecture 1988. Role of insulin resistance in human disease.
###end article-title 85
###begin article-title 86
[Relationship between calpain-10 gene polymorphism, hypertension and plasma glucose].
###end article-title 86
###begin article-title 87
Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population.
###end article-title 87
###begin article-title 88
SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study.
###end article-title 88
###begin article-title 89
Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese.
###end article-title 89
###begin article-title 90
Variants of calpain-10 gene and its association with type 2 diabetes mellitus in a Chinese population.
###end article-title 90
###begin article-title 91
Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.
###end article-title 91
###begin article-title 92
Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes.
###end article-title 92
###begin article-title 93
[Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia].
###end article-title 93
###begin article-title 94
Follow-up report on the diagnosis of diabetes mellitus.
###end article-title 94
###begin article-title 95
###xml 130 133 <span type="species:ncbi:9606">man</span>
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
###end article-title 95
###begin article-title 96
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
###end article-title 96
###begin article-title 97
The metabolic syndrome-a new worldwide definition.
###end article-title 97
###begin article-title 98
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom.
###end article-title 98
###begin article-title 99
Real-time DNA sequencing using detection of pyrophosphate release.
###end article-title 99
###begin article-title 100
From genotypes to genes: doubling the sample size.
###end article-title 100
###begin article-title 101
A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm.
###end article-title 101
###begin article-title 102
Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.
###end article-title 102
###begin article-title 103
###xml 108 113 <span type="species:ncbi:9606">human</span>
Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells.
###end article-title 103
###begin article-title 104
[Single nucleotide polymorphisms and genotype combinations in calpain-10 gene of Korean population].
###end article-title 104
###begin article-title 105
Haplotype structure and phylogenetic shadowing of a hypervariable region in the CAPN10 gene.
###end article-title 105
###begin article-title 106
Population genetics of CAPN10 and GPR35: implications for the evolution of type 2 diabetes variants.
###end article-title 106
###begin article-title 107
Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?
###end article-title 107
###begin article-title 108
Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans.
###end article-title 108
###begin article-title 109
The gonadotropic function of insulin.
###end article-title 109
###begin article-title 110
###xml 21 25 <span type="species:ncbi:10090|species:ncbi:10095">ArKO</span>
###xml 27 31 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity.
###end article-title 110
###begin p 111
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 111
###begin p 112
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work has been partially funded by the Ministerio de Ciencia y Tecnologia of Spain (FIT-010000-2003-36, FIT-010000-2003-89, FIT-0100002003-70, PTQ2003-0783, PTQ2003-0546 and PTQ2003-0549). It has been also supported by grants FISS 03/1618 from Fondo de Investigaciones Sanitarias, a grant from Red de Centros RCMN (C03/08), Madrid, Spain and by CIBERDEM (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 112

